At low 514-nm laser intensity, individual bright viral particles exhibited a moderate decrease in intensity over a time-span of 100 s, while at intermediate and high excitation intensities, the largest proportion of the fluorescent particles photobleached.
In fact, at the highest concentration, naked mole-rats showed a moderate decrease in response latencies over time, reaching a maximum decrease at ∼60 minutes after application (Fig. 2D).
As well as small improvements in QoL over time in patients in contact with ACT, we found a small to moderate decrease in unmet needs over time.
Under severe hypoxia, all of these NTs were significantly downregulated, with the exception of ENT3, whereas under DMOG treatment, a moderate decrease in the expression of ENT1 3 was observed, while CNT3 was reduced by over 80%.
The red fraction exhibits a moderate decrease with increasing redshift.
Consumer confidence improved in December, following a moderate decrease in November.
Nine participants displayed a moderate decrease in antisaccade peak velocity (average effect size, 0.58 ± 0.58) with the placebo.
A moderate decrease in the blood pressure was noticed after salbutamol administration and dobutamine was continuously administered over the entire procedure to maintain the MAP in the range of 69 to 72 mmHg.
The rest of the compounds showed moderate decrease in hypertension.
There was a moderate decrease after 24 hours.
